1. Home
  2. WORX vs XBIO Comparison

WORX vs XBIO Comparison

Compare WORX & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCWorx Corp.

WORX

SCWorx Corp.

N/A

Current Price

$0.15

Market Cap

4.3M

ML Signal

N/A

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$2.53

Market Cap

5.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WORX
XBIO
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
2
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
5.2M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
WORX
XBIO
Price
$0.15
$2.53
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
16.7M
20.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
79.79
N/A
EPS
N/A
N/A
Revenue
$2,989,599.00
N/A
Revenue This Year
N/A
$1.99
Revenue Next Year
N/A
$20.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$1.90
52 Week High
$1.37
$13.93

Technical Indicators

Market Signals
Indicator
WORX
XBIO
Relative Strength Index (RSI) 37.85 57.98
Support Level N/A $2.47
Resistance Level $0.23 $2.76
Average True Range (ATR) 0.05 0.17
MACD -0.02 0.03
Stochastic Oscillator 8.93 78.72

Price Performance

Historical Comparison
WORX
XBIO

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: